These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2216461)

  • 1. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
    Banks L; Edmonds C; Vousden KH
    Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.
    Alunni-Fabbroni M; Littlewood T; Deleu L; Caldeira S; Giarrè M; Dell' Orco M; Tommasino M
    Oncogene; 2000 May; 19(19):2277-85. PubMed ID: 10822378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
    Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S
    Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
    Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
    Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of transformation by the human papillomaviruses.
    Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
    Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
    Tavis JE; Trowbridge PW; Frisque RJ
    Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.
    Stöppler H; Stöppler MC; Adduci A; Koval D; Schlegel R
    Virology; 1996 Mar; 217(2):542-53. PubMed ID: 8610446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular proteins that are targetted by DNA tumor viruses for transformation.
    Dyson N; Buchkovich K; Whyte P; Harlow E
    Princess Takamatsu Symp; 1989; 20():191-8. PubMed ID: 2488232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.
    Chemes LB; Sánchez IE; Smal C; de Prat-Gay G
    FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages.
    Banks L; Moreau F; Vousden K; Pim D; Matlashewski G
    J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
    Boyer SN; Wazer DE; Band V
    Cancer Res; 1996 Oct; 56(20):4620-4. PubMed ID: 8840974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
    Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
    Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.
    Jones DL; Thompson DA; Münger K
    Virology; 1997 Dec; 239(1):97-107. PubMed ID: 9426450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
    Barbosa MS; Edmonds C; Fisher C; Schiller JT; Lowy DR; Vousden KH
    EMBO J; 1990 Jan; 9(1):153-60. PubMed ID: 2153075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
    Prathapam T; Kühne C; Banks L
    Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.